Table 1. Table 1. Patient and tumors characteristics.
| n = 86 | ||
| Age (years) | 68.6±17.5 | |
| Men/Women | 39/47 | |
| Tumor location | ||
| rectum | 6 (7.0%) | |
| left colon | 22 (25.6%) | |
| right colon | 55 (63.9%) | |
| unknown | 3 (3.5%) | |
| Wall invasion | ||
| T1 | 3 (3.5%) | |
| T2 | 2 (2.3%) | |
| T3 | 47 (54.6%) | |
| T4 | 29 (33.7%) | |
| unknown | 5 (5.8%) | |
| Node invasion | ||
| N0 | 44 (51.1%) | |
| N+ | 35 (40.7%) | |
| unknown | 7 (8.1%) | |
| TNM stage | ||
| I | 5 (5.8%) | |
| II | 39 (45.3%) | |
| III | 25 (29.0%) | |
| IV | 10 (11.6%) | |
| unknown | 7 (8.1%) | |
| Tumoral differentiation | ||
| well | 42 (48.8%) | |
| moderate | 22 (25.6%) | |
| poor | 15 (17.4%) | |
| unknown | 7 (8.1%) | |
| VELIPI | ||
| no | 35 (40.7%) | |
| yes | 39 (45.3%) | |
| unknown | 12 (13.9%) | |
| MMR mutation | 16 (18.6%) | |
| Adjuvant chemotherapy | 21 (24.4%) | |
| Disease recurrence | 16 (18.6%) | |
| Death | 37 (43.0%) | |
| due to cancer | 31 (36.0%) | |
| other causes | 6 (7.0%) | |
| DFS (months) | not reached | |
| Overall survival (months) | 72.1±11.3 |
n: number of patients, VELIPI: vascular emboli or lymphatic invasion or perineural invasion.